Keyphrases
Polymyalgia Rheumatica
100%
Giant Cell Arteritis
100%
Clinical Uncertainty
100%
Long Axial Field of View PET
100%
Positron Emission Tomography-computed Tomography (PET-CT)
66%
18F-FDG Positron Emission Tomography
50%
FDG Positron Emission Tomography/computed Tomography
50%
Long Axial Field of View
50%
High Quality Images
33%
Malignancy
16%
Differential Diagnosis
16%
Inflammation
16%
Clinical Data
16%
PET Imaging
16%
Radiation Exposure
16%
Anemia
16%
Tracer Dose
16%
Laboratory Parameters
16%
Diagnostic Work-up
16%
Clinical Presentation
16%
Limited Availability
16%
Tomography System
16%
18F-fluorodeoxyglucose (18F-FDG)
16%
Inflammatory Parameters
16%
Imaging Time
16%
Inconvenience
16%
Laboratory Data
16%
Fluorine-18 Fluorodeoxyglucose
16%
Low Spatial Resolution
16%
Non-specific Symptoms
16%
Symptom Parameter
16%
Scan Duration
16%
Autoimmune Pathology
16%
Fluorodeoxyglucose 18F
16%
Medicine and Dentistry
Giant-Cell Arteritis
100%
Positron Emission Tomography
100%
Positron Emission Tomography-Computed Tomography
100%
Clinical Uncertainty
100%
Polymyalgia Rheumatica
100%
Fluorodeoxyglucose F 18
66%
Image Quality
33%
Infection
16%
Symptom
16%
Diagnosis
16%
Fluorine-18
16%
Radiation Exposure
16%
Radioactive Tracer
16%
Positron Emission Tomography
16%
Anemia
16%
Cancer
16%
Autoimmune Disease
16%
Differential Diagnosis
16%
Physical Disease by Body Function
16%
Fluorodeoxyglucose
16%